These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 34638620)

  • 1. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.
    Hartman GD; Lambert-Cheatham NA; Kelley MR; Corson TW
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization.
    Li Y; Liu X; Zhou T; Kelley MR; Edwards P; Gao H; Qiao X
    Redox Biol; 2014; 2():485-94. PubMed ID: 24624338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.
    Jiang A; Gao H; Kelley MR; Qiao X
    Vision Res; 2011 Jan; 51(1):93-100. PubMed ID: 20937296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity.
    Li Y; Liu X; Zhou T; Kelley MR; Edwards PA; Gao H; Qiao X
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4461-9. PubMed ID: 24970265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
    Eyetech Study Group
    Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
    Laev SS; Salakhutdinov NF; Lavrik OI
    Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APE1/Ref-1 as a Novel Target for Retinal Diseases.
    Heisel C; Yousif J; Mijiti M; Charizanis K; Brigell M; Corson TW; Kelley MR
    J Cell Signal; 2021; 2(2):133-138. PubMed ID: 34322687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
    Andreoli CM; Miller JW
    Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease.
    Muniyandi A; Hartman GD; Song Y; Mijit M; Kelley MR; Corson TW
    J Pharmacol Exp Ther; 2023 Jul; 386(1):15-25. PubMed ID: 37142441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives on established and novel therapies for pathological neovascularization in retinal disease.
    Campbell M; Doyle SL
    Biochem Pharmacol; 2019 Jun; 164():321-325. PubMed ID: 31039332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease.
    Sahakian L; Robinson AM; Sahakian L; Stavely R; Kelley MR; Nurgali K
    Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.
    Kelley MR; Georgiadis MM; Fishel ML
    Curr Mol Pharmacol; 2012 Jan; 5(1):36-53. PubMed ID: 22122463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization.
    Sardar Pasha SPB; Sishtla K; Sulaiman RS; Park B; Shetty T; Shah F; Fishel ML; Wikel JH; Kelley MR; Corson TW
    J Pharmacol Exp Ther; 2018 Oct; 367(1):108-118. PubMed ID: 30076264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.
    Bandello F; Corvi F; La Spina C; Benatti L; Querques L; Capuano V; Naysan J; Chen X; Sarraf D; Parodi MB; Souied E; Freund KB; Querques G
    Br J Ophthalmol; 2016 Dec; 100(12):1611-1616. PubMed ID: 26951773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
    Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
    Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multifunctional APE1 DNA repair-redox signaling protein as a drug target in human disease.
    Caston RA; Gampala S; Armstrong L; Messmann RA; Fishel ML; Kelley MR
    Drug Discov Today; 2021 Jan; 26(1):218-228. PubMed ID: 33148489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.
    Mijit M; Liu S; Sishtla K; Hartman GD; Wan J; Corson TW; Kelley MR
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
    Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
    Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis.
    Sahakian L; Filippone RT; Stavely R; Robinson AM; Yan XS; Abalo R; Eri R; Bornstein JC; Kelley MR; Nurgali K
    Inflamm Bowel Dis; 2021 Feb; 27(3):388-406. PubMed ID: 32618996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.